Skip to main content
Caplight Logo









VINS Bioproducts Limited

VINS Bioproducts Limited

Private
HyderabadHealthcare & Life Scienceshttps://vinsbio.in/

Last Round

Accelerator

May 1, 2020

Company Overview

VINS Bioproducts Limited is a biotechnology company that develops and manufactures life-saving antisera and immunoglobulins for treating critical conditions arising from venomous bites and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2G

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antiseraantitoxinanti-snake venomASVSbiopharmaceutical manufacturinganti-rabies serumARSimmunobiologicalsequine-derived medicinesnake antivenomimmunoglobulinstetanus antitoxindiphtheria antitoxinbiologics supplieremergency medical suppliestropical disease treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VINS Bioproducts Limited Comparables

Compare VINS Bioproducts Limited with similar companies based on industry and business-model similarity.

VINS Bioproducts Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Premium Serums and Vaccines Private Limited
92%
Inosan Biopharma
83%
Haffkine Bio-Pharmaceutical Corporation Limited
80%

VINS Bioproducts Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 1, 2020

Key People

Founding team and executive leadership

Ajit Nair

CEO

Executive Team

Khushboo Mundra Daga

Chief Executive Officer

Executive Team

Siddarth Daga

CEO

Executive Team

VINS Bioproducts Limited Investors

Notable investors and investment history

VINS Bioproducts Limited investors
InvestorRounds
ASPIRE-BioNESTAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 90% MoM.

  • Nov 15, 2024

    Grew 3250% QoQ, from 4 to 134 employees.

VINS Bioproducts Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VINS Bioproducts Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VINS Bioproducts Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersHyderabad
Employee Range166
Year Founded1997
Last FundingMay 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?